Docetaxel (X-GEN Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Docetaxel drug offered from X-GEN Pharmaceuticals, Inc.. This Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: X-GEN Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: docetaxel
SUBSTANCE NAME: DOCETAXEL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Microtubule Inhibition [PE],Microtubule Inhibitor [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION, CONCENTRATE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-04-17
END MARKETING DATE: 0000-00-00


Docetaxel HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDocetaxel from X-GEN Pharmaceuticals, Inc.
LABELER NAME: X-GEN Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/mL)
START MARKETING DATE: 2017-04-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 39822-2120_9c81403e-61cf-4381-9bba-db04f665c47d
PRODUCT NDC: 39822-2120
APPLICATION NUMBER: ANDA206177

Other DOCETAXEL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Docetaxel
Dr. Reddy’s Laboratories Inc.Docetaxel
Eagle Pharmaceuticals, Inc.Docetaxel
Hospira, Inc.Docetaxel
Jiangsu Hengrui Medicine Co., Ltd.Docetaxel
Sandoz IncDocetaxel
sanofi-aventis U.S. LLCTAXOTERE
Winthrop U.S.Docetaxel
X-GEN Pharmaceuticals, Inc.Docetaxel